August 19, 2026
Quantum BioPharma’s Lucid-MS Targets Myelin Protection as New Approach to MS Treatment
August 19, 2026
Earth Science Tech Acquires Zoolzy to Strengthen Pharmaceutical Supply Chain and Enter Veterinary Market
August 19, 2026
Earth Science Tech Expands West Coast Presence with Acquisition of California Compounding Pharmacy
August 19, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Trials as MS Treatment Focus Expands Beyond Inflammation
August 18, 2026
Regentis Biomaterials Secures Japanese Patent for GelrinC Manufacturing, Boosting Commercialization Prospects
August 18, 2026
SS Innovations Reports Record Q2 Revenue, Advances SSi Mantra Robotic Surgery Platform
August 18, 2026
Freyja Healthcare’s VereSee Mini Laparoscope Receives FDA Clearance, Promising Enhanced Visualization During Surgical Entry
August 17, 2026
Helix BioPharma Appoints Dr. Markus Loeffler as Chief Medical Officer to Drive Next Phase of Oncology Clinical Development
August 17, 2026
Regentis Biomaterials Advances GelrinC on Parallel U.S. Clinical and European Commercial Paths
August 17, 2026
Dyadic International Secures $2.9 Million in Registered Direct Offering and Private Placement
August 17, 2026
Alpha Cognition’s ZUNVEYL Demand Surges, Setting Stage for Growth Despite Payer Headwinds
August 16, 2026
Morpheus8 RF Microneedling Now Available in Burley, Idaho, Offering Local Skin Tightening Option
August 14, 2026
Vycor Medical Reports Mixed Q2 2026 Results, Highlighting VBAS Clinical Evidence Growth
August 14, 2026
Onco-Innovations Advances ONC010 Toward First-in-Human Trials with Key Manufacturing and Metabolic Studies
August 14, 2026
Regentis Biomaterials Secures Japanese Patent for GelrinC Manufacturing Process, Strengthening Global Cartilage Repair Position
August 14, 2026
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Option in Knee Cartilage Repair Market
August 14, 2026
Quantum BioPharma Cuts Costs, Advances Multiple Sclerosis Drug to Phase 2 After FDA Approval
August 14, 2026
Regentis Biomaterials Advances GelrinC with Parallel U.S. Clinical and European Commercial Strategies
August 14, 2026
Redwood AI Completes Acquisition of Quantum.IQ Technologies to Bolster Quantum Cybersecurity
August 14, 2026
Helus Pharma Completes Enrollment in Pivotal Phase 3 Depression Trial, Targets Q4 2026 Data
August 13, 2026
Burcon Nutrascience’s Q1 Results Signal Shift to Commercial Execution, Says Stonegate
August 13, 2026
NeOnc’s NEO100 Shows Strong Survival Signal in Phase 2a, Paving Way for Regulatory Discussions
August 13, 2026
PX1 Research Releases USA-Made Retatrutide and Tirzepatide Peptides with 99%+ Purity Verified by HPLC
August 13, 2026
Quantum BioPharma’s Lucid-MS Targets Disability Drivers Beyond Relapse in Multiple Sclerosis
